Use of psychotropic medications in young, preschool children: Primum non nocere

Archives of Pediatrics and Adolescent Medicine

Volumn 157, Issue 2, 2003, Pages 121-123

  Barbaresi, William J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CENTRAL STIMULANT AGENT; PSYCHOTROPIC AGENT;

ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CHILD BEHAVIOR; CHILD DEVELOPMENT; CHILD HEALTH CARE; DRUG USE; EDITORIAL; EMOTION; GENERAL PRACTITIONER; HEALTH CARE PLANNING; HUMAN; MEDICAL DECISION MAKING; MEDICAL PRACTICE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL;

EID: 0037299770     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.157.2.121     Document Type: Editorial

References (5)

1. DeBar LL, Lynch F, Powell J, Gale J. Use of psychotropic agents in preschool children: associated symptoms, diagnoses, and health care services in a health maintenance organization. Arch Pediatr Adolesc Med. 2003;157:150-157.
2. Rappley MD, Mullan PB, Alvarez FJ, Eneli IU, Wang J, Gardiner JC. Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children. Arch Pediatr Adolesc Med. 1999;153:1039-1045.
3. Zito JM, Safer DJ, dosReis S, Gardner JF, Boyles M, Lynch F. Trends in the prescribing of psychotropic medications to preschoolers. JAMA. 2000;283:1025-1030.
4. US Census Bureau. American FactFinder Page. United States Census 2000. Available at: http://factfinder.census.gov/servlet/BasicFactsServlet. Accessed November 11, 2002.
5. Barbaresi WJ, Katusic SK, Colligan RC, et al. How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn. Arch Pediatr Adolesc Med. 2002;156:217-224.